#BioRxiv

Christian Schöb

ChristianSchob

The #Crop #Diversity #Experiment funded by @snf_ch can show first results available on @biorxivpreprint. First year results from #Switzerland show 21% and 44% increases in yield in 2- and 4-species

Zamin Iqbal

ZaminIqbal

Delighted to see our latest paper now available on biorxiv: https://www.biorxiv.org/content/10.1101/2020.11.12.380378v1In this study, we set out to solve the problem of SNP calling in bacterial pan-genomes. What problem, you say?

Anna Lipkin

anna_lipkin

So excited to share my first paper from grad school, up on bioRxiv today! With @mmcunniff, @PerrySpratt, @StefanMLemke, and @NeuroBender, we show that calcium channels are organized into distinct functional

Laura Henderson

SixandLaura

“Scientists chase cause of mysterious vaping illness as death toll risesConfusion reigns as researchers sort through the complex US e-cigarette market.” 10/11/2019 #EVALIhttps://www.nature.com/articles/d41586-019-03033-1 “Highly funct

Nicolas Vabret

neoviral

A few thoughts about this preprint claiming that SARS-COV-2 is reverse-transcribed into human genome (1/7)https://www.biorxiv.org/content/10.1101/2020.12.12.422516v1 The human/viral chimeric reads that the authors detect in RNAseq dataset d

Matteo Carandini

MatteoCarandini

The brain meets a myriad behavioral demands with a limited number of neurons. Does it use the same neurons across behaviors? We addressed this question in mouse parietal cortex, where

Carl T. Bergstrom

CT_Bergstrom

Over the past nine months I've written occasionally about the prospects for the SARS-CoV-2 virus to evolve into a less (or more) virulent form. In general, we can't count on

Josh - Data Analyst in Nashville

ifihadastick

There is an incredibly stupid and and anti-science myth that is circulating around- that there is no immunity post-infection to Covid. Here's a few papers I've read and the summary

Johan Jakobsson

JakobssonLab

1/ A quick review of this preprint, since it is potentially very important for the pandemic and the novel mRNA vaccines and since it relates to my expertise. In my

Björn Meyer

_b_meyer

The mutation 501Y, which is present in both lineages from the UK (501Y.V1) and SA (501Y.V2) shows an increased affinity to the entry receptor Ace2. This was mainly known already.

Zenab Tamimy

zenabtamimy

(1/6) Remember how I was stuck in the US due to covid, after visiting the statistical genetics workshop in Boulder? Well, worth it! A lecture of Mike Hunter on multilevel

Zack Chiang

z_chiang

Interesting thread on a new genomic technology getting a lot of hype. But until they release more details on how their method actually works, this is an ad, not sciencehttps://twitter.com/bionanogenomics/status/1347213793827442690

Vaughn Cooper

vscooper

A long time ago, in a cozy @UofNH lab, @GeiselBiofilm suggested we do a biofilm evolution experiment with P. aeruginosa PA14. To nobody's surprise, the populations diversified, but the extent

Kevin Ng

KevinWNg

An updated version of our manuscript on antibody cross-reactivity between seasonal coronaviruses and SARS-CoV-2 is now online:https://www.biorxiv.org/content/10.1101/2020.05.14.095414v2 Plenty of new data in this version, including a proper

Willem van Schaik 💙

WvSchaik

Our latest paper ‘Microbiota analysis of rural and urban surface waters and sediments in Bangladesh identifies human waste as driver of antibiotic resistance’ is now on @biorxivpreprint: https://www.biorxiv.org/content/10.1101/2021.02.0

Patrik Simmler

PatrikSimmler

I am happy to share our preprint about the #splicing factor SF3B1 that contributes to tumor malignancy by facilitating the adaption to hypoxia in solid cancers. SF3B1 interacts with #HIF1α

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.